Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Vytenis Kalibatas"'
Blood donations and donors’ profile in Lithuania: Trends for coming back after the COVID-19 outbreak
Publikováno v:
PLoS ONE, Vol 19, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/45ac975d8e714a2db5bd9aab8dd7e917
Autor:
Bernadeta Zykienė, Vytenis Kalibatas
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Nonattendance is a common problem worldwide. Important factors for nonattendance are a queue or the waiting time until the planned service. Aims The aims of this study were to identify the reasons for nonattendance to planned cons
Externí odkaz:
https://doaj.org/article/a7d880c91652484fbd61207cf413f630
Autor:
Vytenis Kalibatas, Lina Kalibatienė
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0277650 (2022)
Lithuania has a long history of remunerated donations. The first steps towards voluntary, non-remunerated blood and blood component donations started in 2004. Lithuania achieved 99.98% voluntary non-remunerated donations (VNRDs) in 2020. This study a
Externí odkaz:
https://doaj.org/article/b2e196ec7591423b834c6189e66a506d
Publikováno v:
Inquiry: The Journal of Health Care Organization, Provision, and Financing, Vol 58 (2021)
Aims Lithuania is one of the countries where public and private primary health care (PHC) providers compete for patients. Patients continuously shift from public to PHC providers, but an analysis of the main reasons was never performed. This study ai
Externí odkaz:
https://doaj.org/article/b3c4b54f6e07458d9def16ba65fec8b7
Publikováno v:
Medicina, Vol 51, Iss 3, Pp 180-186 (2015)
Objective: The aim of this study was to evaluate the effectiveness and safety of oral midazolam in children undergoing dental surgery. Materials and methods: A prospective, randomized, controlled trial was conducted to assess the effectiveness and sa
Externí odkaz:
https://doaj.org/article/37080b6ad4cd473592f23994036404f8
Autor:
Nico Lelie, Ewa Brojer, Michael P. Busch, Harry van Drimmelen, Piotr Grabarczyk, Susan L. Stramer, C. Micha Nübling, Annie Girault, Syria Laperche, Faten Moftah, Magdy El Elkyabi, Vytenis Kalibatas, Hiroshi Yoshizawa
Publikováno v:
Transfusion. 55:2489-2498
BACKGROUND Hepatitis C virus (HCV) antigen and antibody combination assays have been launched as a cost-effective alternative to nucleic acid testing (NAT) for reducing the antibody-negative window period (WP). Later, a HCV antigen chemiluminescence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::011ccb1bcbe38b16f5db2e9d3d31e04f
https://doi.org/10.1111/trf.13179
https://doi.org/10.1111/trf.13179
Autor:
Simonas Juzenas, Jurgita Sventoraityte, Vytenis Kalibatas, Limas Kupčinskas, Laimutis Kučinskas, Jurate Kondrackiene, Astra Vitkauskiene, Ruta Cedaviciute
Publikováno v:
Annals of Hematology. 91:491-495
HFE-hemochromatosis is a common autosomal recessive disease caused by HFE gene mutations and characterized as iron overload and failure of different organs. The aim of this study was to determine the prevalence of C282Y (c.845 G > A), H63D (c.187 C >
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e946cc3877b30fa56ec07d5cd8688af4
https://doi.org/10.1007/s00277-011-1338-5
https://doi.org/10.1007/s00277-011-1338-5
Autor:
Vytenis Kalibatas
Publikováno v:
Vox Sanguinis. 95:74-326
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1debac15e2922473035eb0797a03af25
https://doi.org/10.1111/j.1423-0410.2008.01056.x
https://doi.org/10.1111/j.1423-0410.2008.01056.x
Autor:
Vytenis Kalibatas
Publikováno v:
Vox Sanguinis. 94:209-215
Background and Objectives In Lithuania, remuneration for whole blood donations still prevails, with the government covering payment for the donors. The payment per donation in cash is equal to 40 litas (€11·6); it is offered to all blood donors an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a57d3fa8009f11abe4ee73c658a41487
https://doi.org/10.1111/j.1423-0410.2007.01015.x
https://doi.org/10.1111/j.1423-0410.2007.01015.x
Autor:
Syria, Laperche, C Micha, Nübling, Susan L, Stramer, Ewa, Brojer, Piotr, Grabarczyk, Hiroshi, Yoshizawa, Vytenis, Kalibatas, Magdy, El Elkyabi, Faten, Moftah, Annie, Girault, Harry, van Drimmelen, Michael P, Busch, Nico, Lelie
Publikováno v:
Transfusion. 55(10)
Hepatitis C virus (HCV) antigen and antibody combination assays have been launched as a cost-effective alternative to nucleic acid testing (NAT) for reducing the antibody-negative window period (WP). Later, a HCV antigen chemiluminescence immunoassay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6c4991641e80d581fa20e81497a3f874
https://pubmed.ncbi.nlm.nih.gov/26013970
https://pubmed.ncbi.nlm.nih.gov/26013970